Primary Repair of Common Arterial Trunk
Primary Repair of Common Arterial Trunk:
A Contemporary Perspective on Outcomes & Innovation
Congenital heart disease continues to test the limits of modern cardiovascular surgery. Among its rarest and most complex anomalies is the common arterial trunk (also known as truncus arteriosus), a condition where a single arterial trunk arises from the heart to supply the systemic, pulmonary, and coronary circulations. Without prompt surgical intervention, this defect is uniformly fatal due to early-onset congestive heart failure and pulmonary overcirculation.
While surgical correction has evolved dramatically since its first description in the 1960s, the primary repair of common arterial trunk remains challenging. The rarity of the condition, coupled with its anatomic complexity, has resulted in limited, fragmented data and persistent debate regarding optimal timing, technical strategies, and long-term conduit management.
A recent systematic review and meta-analysis by the Italian Research Group on Outcome in Cardiac Surgery aimed to address this gap by pooling available data to quantify both early and late outcomes of primary repair. The analysis, encompassing 43 studies and 4,844 patients, offers a contemporary benchmark against which future innovations can be measured.
This article synthesizes the findings of that meta-analysis, places them in clinical context, and explores innovations shaping the future of common arterial trunk repair.
The Study at a Glance
Common arterial trunk represents less than 1% of congenital heart defects. It is characterized by:
A single arterial outflow from the heart
Varying truncal valve morphology, often with regurgitation
A large ventricular septal defect (VSD)
Frequently associated anomalies, including interrupted aortic arch or abnormal coronary patterns
The surgical principle is to :
- Separate systemic and pulmonary circulations, closing the VSD and directing left ventricular output to the systemic arterial trunk.
- Establish right ventricular–pulmonary artery continuity typically via a valved conduit.
Yet, despite technical advances, surgical repair is burdened by high early mortality and reoperation rates, especially related to conduit failure. The timing of intervention—neonatal versus later infancy—has long been debated, balancing risks of early surgery against the progressive damage of prolonged pulmonary overcirculation.
The Meta-Analysis at a Glance
The Italian Research Group performed an extensive search of PubMed, Google Scholar, Ovid-MEDLINE, and EMBASE, selecting studies reporting early mortality after primary repair.
Notably, no significant difference in early mortality was observed between single-center and multicenter studies, suggesting that institutional experience may not fully mitigate the inherent surgical risks.
What the Numbers Tell Us
1. Early Mortality Remains a Concern
Despite decades of surgical evolution, an early mortality of ~11% underscores the complexity of the condition. While modern techniques and perioperative care have improved outcomes, primary repair of common arterial trunk remains riskier than many other congenital repairs.
2. Neonatal Repair Shows a Survival Advantage
Perhaps the most practice-informing finding is the lower mortality in neonatal repairs compared with those performed later in infancy. This supports the emerging consensus that earlier intervention—before pulmonary vascular disease and irreversible myocardial remodeling occur—may confer better outcomes.
2. Conduit Reoperations Are the Achilles’ Heel
The meta-analysis highlights a 3.4% annual reoperation rate on the right ventricle–pulmonary artery (RV-PA) conduit. Over a decade, this translates into a significant cumulative burden of reinterventions, often requiring complex redo sternotomies. This is not merely a technical inconvenience; each reoperation carries incremental risks, impacts quality of life, and increases healthcare costs.
Surgical Techniques:
Evolution and Innovation
Over time, surgical strategies have evolved with the aim of improving both survival and durability.
Classical Approach :
- Closure of VSD with routing of left ventricular outflow to the truncal root
- Use of a valved homograft or heterograft conduit to connect the RV to the pulmonary arteries
- While effective, this approach remains limited by conduit degeneration
Innovative Strategies :
Conduit-less Repairs (Autologous or Synthetic Tissue Reconstruction)
Some centers have experimented with direct RV-PA continuity using autologous tissue flaps or synthetic grafts, aiming to avoid conduit-related complications.
Valve-sparing Techniques
In patients with competent truncal valves, efforts are made to preserve native valve tissue to reduce the risk of future valvular dysfunction.
Hybrid and Staged Interventions
Combining catheter-based palliation with delayed surgical correction has been explored in selected high-risk neonates.
Next-Generation Valved Conduits
Tissue-engineered grafts and decellularized homografts are under active investigation, aiming to provide growth potential, reduce immune-mediated degeneration, and limit the need for reoperation.
Clinical Implications
The findings from this meta-analysis reinforce several practice points:
Neonatal repair should be the preferred timing
whenever feasible, as early correction appears to improve survival.
Durable conduit technology
remains the most pressing innovation need. Until a reliable, growth-accommodating RV-PA conduit is available, reoperation will remain common.
Centralization of care
performing these rare, complex repairs in high-volume congenital centers—may optimize surgical planning, postoperative care, and access to novel grafts and devices.
Future Directions:
Towards a Growth-Adaptive Solution
Efforts are underway to develop living grafts capable of growth, self-repair, and resistance to calcification. Stem cell–seeded scaffolds, bioresorbable polymers, and genetically engineered tissues represent the frontier of congenital cardiac surgery.
Additionally, advanced imaging and computational modeling may allow surgeons to virtually simulate repairs, optimizing conduit sizing, geometry, and flow dynamics before entering the operating room.
Lastly, international registries and collaborative research networks are critical. As this meta-analysis demonstrates, the rarity of common arterial trunk makes single-center studies insufficient to fully answer practice-changing questions. Only through global data sharing can meaningful progress be accelerated.
Conclusion
Primary repair of common arterial trunk remains one of the most challenging operations in congenital heart surgery. Despite significant strides, early mortality remains notable, and conduit-related reoperations are inevitable for most patients.
This meta-analysis provides both a benchmark and a call to action. It validates the strategy of neonatal repair and highlights the urgent need for innovation in conduit technology. For surgeons, cardiologists, and bioengineers alike, the path forward lies in collaborative research, tissue engineering, and personalized surgical planning—transforming a once uniformly fatal malformation into a condition compatible with long-term survival and quality of life.
Reference:
Primary repair of common arterial trunk: A systematic meta-analysis of short- and long-term outcomes
Cuomo, Michela et al.
JTCVS Open, Volume 26, 182 – 195
https://www.jtcvsopen.org/action/showCitFormats?doi=10.1016%2Fj.xjon.2025.05.012&pii=S2666-2736%2825%2900212-8